CY1124623T1 - Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη - Google Patents

Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη

Info

Publication number
CY1124623T1
CY1124623T1 CY20211100528T CY211100528T CY1124623T1 CY 1124623 T1 CY1124623 T1 CY 1124623T1 CY 20211100528 T CY20211100528 T CY 20211100528T CY 211100528 T CY211100528 T CY 211100528T CY 1124623 T1 CY1124623 T1 CY 1124623T1
Authority
CY
Cyprus
Prior art keywords
bacterial strains
compositions containing
containing bacterial
strains
therapy
Prior art date
Application number
CY20211100528T
Other languages
English (en)
Inventor
Samantha YUILLE
Nicole Reichardt
Sarah REID
Suaad AHMED
Helene SAVIGNAC
Imke Elisabeth MULDER
Anna ETTORRE
Original Assignee
4D Pharma Research Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1814836.1A external-priority patent/GB201814836D0/en
Priority claimed from GBGB1905000.4A external-priority patent/GB201905000D0/en
Application filed by 4D Pharma Research Limited filed Critical 4D Pharma Research Limited
Publication of CY1124623T1 publication Critical patent/CY1124623T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση παρέχει συνθέσεις που περιλαμβάνουν βακτηριακά στελέχη για χρήση στη θεραπεία.
CY20211100528T 2018-06-25 2021-06-14 Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη CY1124623T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18179641 2018-06-25
GBGB1814836.1A GB201814836D0 (en) 2018-09-12 2018-09-12 Compositions comprising bacterial strains
GBGB1905000.4A GB201905000D0 (en) 2019-04-09 2019-04-09 Compositions comprising bacterial strains
PCT/EP2019/066905 WO2020002370A1 (en) 2018-06-25 2019-06-25 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
CY1124623T1 true CY1124623T1 (el) 2022-07-22

Family

ID=67667788

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100528T CY1124623T1 (el) 2018-06-25 2021-06-14 Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη

Country Status (22)

Country Link
US (2) US20210085728A1 (el)
EP (2) EP3922256A1 (el)
JP (2) JP6987259B2 (el)
KR (1) KR102383535B1 (el)
CN (1) CN112912090A (el)
AU (2) AU2019294284B2 (el)
CA (1) CA3103161C (el)
CY (1) CY1124623T1 (el)
DK (1) DK3723777T3 (el)
ES (1) ES2887903T3 (el)
HR (1) HRP20210772T1 (el)
HU (1) HUE054904T2 (el)
IL (1) IL279724B (el)
LT (1) LT3723777T (el)
MA (1) MA51185B1 (el)
MD (1) MD3723777T2 (el)
PL (1) PL3723777T3 (el)
RS (1) RS61972B1 (el)
SG (1) SG11202012221YA (el)
SI (1) SI3723777T1 (el)
TW (1) TW202019446A (el)
WO (1) WO2020002370A1 (el)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
JP2019501136A (ja) * 2015-11-24 2019-01-17 セレス セラピューティクス インコーポレイテッド 設計された細菌組成物
EP4368254A2 (en) * 2016-03-14 2024-05-15 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system

Also Published As

Publication number Publication date
MD3723777T2 (ro) 2021-09-30
KR102383535B1 (ko) 2022-04-08
JP6987259B2 (ja) 2021-12-22
LT3723777T (lt) 2021-06-10
AU2019294284A1 (en) 2021-02-04
AU2021204337A1 (en) 2021-07-22
WO2020002370A1 (en) 2020-01-02
JP2021522160A (ja) 2021-08-30
SG11202012221YA (en) 2021-01-28
PL3723777T3 (pl) 2021-10-04
KR20210021085A (ko) 2021-02-24
EP3723777A1 (en) 2020-10-21
MA51185A (fr) 2020-10-21
EP3922256A1 (en) 2021-12-15
RS61972B1 (sr) 2021-07-30
US20210085728A1 (en) 2021-03-25
TW202019446A (zh) 2020-06-01
HRP20210772T1 (hr) 2021-09-17
CN112912090A (zh) 2021-06-04
ES2887903T3 (es) 2021-12-28
CA3103161C (en) 2021-12-14
DK3723777T3 (da) 2021-05-25
IL279724A (en) 2021-03-01
JP2022033856A (ja) 2022-03-02
AU2019294284B2 (en) 2021-03-25
MA51185B1 (fr) 2021-07-29
SI3723777T1 (sl) 2021-08-31
CA3103161A1 (en) 2020-01-02
US20230134714A1 (en) 2023-05-04
IL279724B (en) 2022-05-01
HUE054904T2 (hu) 2021-10-28
EP3723777B1 (en) 2021-03-31

Similar Documents

Publication Publication Date Title
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1125136T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122148T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CY1120373T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1123381T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
CY1125659T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122162T1 (el) Συνθεσεις που περιεχουν bakthpiaka στελεχη
CA211013S (en) Vaporizer device
MD3313423T2 (ro) Compoziții care conțin tulpini bacteriene de Blautia pentru tratamentul hipersensibilității viscerale
MD3240554T2 (ro) Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
MD3307288T2 (ro) Compoziții care conțin tulpini bacteriene
BR112018016450A2 (pt) composições intensificadoras de vcn e métodos de uso das mesmas
CY1125211T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
PH12020551716A1 (en) Anti-ror antibody constructs
CA185542S (en) Table
CY1124286T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
MX2020011027A (es) Constructos de anticuerpos biespecíficos trivalentes.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
CY1124623T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CL2019001121S1 (es) Cepillo de dientes.
CL2019001123S1 (es) Cepillo de dientes.
EA202190554A1 (ru) Композиции, содержащие бактериальные штаммы
MX2021014530A (es) Composiciones de colageno y usos de las mismas.
EA201990275A1 (ru) Композиции, содержащие бактериальные штаммы